← All Signals

🏥 FDA: K.C. Pharmaceuticals, Inc — Class II

healthcareactionableSource: FDA
95%Confidence
0Views
FDASource
2026-04-17Date

Summary

K.C. Pharmaceuticals' sterility assurance failure for multiple eye drop products distributed through major retailers creates significant consumer safety risks. This affects multiple brands including Leader, Good Sense, and Good Neighbor Pharmacy, potentially triggering widespread recalls.

Actionable: Immediately halt distribution and sales of affected eye drop products and initiate recall procedures.

AI Confidence: 95%

Data Points

firmK.C. Pharmaceuticals, Inc
classificationClass II
statusOngoing
distributionNationwide in the US
productArtificial Tears Sterile Lubricant Eye Drops (polyvinyl alcohol 0.5%, povidone 0.6%), 0.5 FL OZ (15 mL) bottles; a) LEADER, DISTRIBUTED BY CARDINAL HE

Get Signals Instantly

Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.

Subscribe Now